Suggestions
Liam Richardson
Content Director - Healthcare at CloserStill Media
Liam Richardson is the Content Director for Healthcare at CloserStill Media, a position he has held since 2023. He joined CloserStill Media in January 2021 as Head of Content for Healthcare and has since been promoted to his current role.13
Professional Background
Liam has over a decade of experience in event production and the healthcare industry.24 His career at CloserStill Media has progressed as follows:
- 2021-2023: Head of Content - Healthcare
- 2023-present: Content Director - Healthcare
Responsibilities and Expertise
As Content Director, Liam is responsible for overseeing content strategy and production for CloserStill Media's healthcare events. His extensive experience in event production makes him well-suited for this role.2 He is based at Exhibition House, CloserStill's head office in central London.3
Recent Activities
Liam has been actively involved in CloserStill Media's events and initiatives. Recently, he highlighted nominations for the company and praised his colleagues Agnes Jacobs and Emma Pappenheim for their achievements.5
CloserStill Media
CloserStill Media is a prominent events company that organizes exhibitions and conferences across various industries, including healthcare, technology, and education. The company has been recognized for its rapid growth and success in the events industry.1
Highlights
📰 New report - Men's health: the lives of men in our communities published today by Local Government Association.
Described as a "silent health crisis" which should be something of "national concern", the report finds: 🔴 men in deprived areas living up to 10 years less than in affluent areas 🔴 high levels of smoking and excessive drinking 🔴 four out of five suicides are men
The full report includes a call to action and case studies from local councils doing innovative work in this area
https://lnkd.in/eJpUnmbD
#menshealth #publichealth #nhs #primarycare #localgovernment
Really disappointing news on Lecanemab today - a new drug which can slow the progression of Alzheimer's.
The drug was approved by Medicines and Healthcare products Regulatory Agency. Follows the FDA approval earlier in year and ahead of other EU countries.
However, even though it has been licensed, NICE - National Institute for Health and Care Excellence have evaluated the cost versus the benefits aren't sufficient for it to be approved on the NHS.
A blow for patients and campaigners on this issue. A BBC documentary - The Jennings vs Alzheimer's - covers in lot of detail the personal journey and development over time of a drug to combat the disease. Recommended viewing.
#healthcareinnovation #Alzheimersdisease #healthcarepolicy #NHS
